Mistletoe Therapy in the News: Announcing Johns Hopkins Clinical Trials Phase I.

Published findings in the peer-reviewed academic journal Cancer Research Communications gains media coverage. The Baltimore Sun dedicated a front-page article to the highly anticipated study revealing many significant conclusions. (A version of the article can be found here). With the abundance of positive results from the Phase 1 Clinical Trial of Intravenous Mistletoe Extract in Advanced Cancer researchers achieve necessary momentum to proceed to Phase 2.